Sarah Naeger1, Mir M Ali1, Ryan Mutter1, Tami L Mark1, Lauren Hughey1. 1. Dr. Naeger, Dr. Ali, and Dr. Mutter are with the Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Rockville, Maryland. Dr. Mark and Ms. Hughey are with the Department of Behavioral Health and Quality Research, Truven Health Analytics, an IBM company, Bethesda, Maryland. Send correspondence to Dr. Ali (e-mail: mir.ali@samhsa.hhs.gov ).
Abstract
OBJECTIVE: The purpose of this study was to identify patterns of postdischarge prescription fills following an opioid-related hospitalization. METHODS: Using the 2010-2014 MarketScan Commercial Claims and Encounters database, this analysis identified the percentage of patients (N=36,719) with an opioid-related inpatient admission who received substance use disorder treatment medications within 30 days of being discharged. RESULTS: Thirty-five percent of the sample did not have any prescription fills in the 30-day postdischarge period. Less than a quarter (16.7%) of patients received any FDA-approved opioid dependence medication in the 30 days following discharge. Forty percent of patients in the sample received antidepressants, 15.6% received antipsychotics, 13.9% filled a prescription for a benzodiazepine, and 22.4% filled a prescription for an opioid pain medication. CONCLUSIONS: More effort is needed to ensure that patients hospitalized for opioid misuse are receiving recommended services.
OBJECTIVE: The purpose of this study was to identify patterns of postdischarge prescription fills following an opioid-related hospitalization. METHODS: Using the 2010-2014 MarketScan Commercial Claims and Encounters database, this analysis identified the percentage of patients (N=36,719) with an opioid-related inpatient admission who received substance use disorder treatment medications within 30 days of being discharged. RESULTS: Thirty-five percent of the sample did not have any prescription fills in the 30-day postdischarge period. Less than a quarter (16.7%) of patients received any FDA-approved opioid dependence medication in the 30 days following discharge. Forty percent of patients in the sample received antidepressants, 15.6% received antipsychotics, 13.9% filled a prescription for a benzodiazepine, and 22.4% filled a prescription for an opioid pain medication. CONCLUSIONS: More effort is needed to ensure that patients hospitalized for opioid misuse are receiving recommended services.
Authors: Christopher Griggs; Stephen Wyatt; Meghan K Wally; Michael Runyon; Joseph R Hsu; Rachel B Seymour; Michael Beuhler; Michael J Bosse; Ryan Fogg; Michael Gibbs; Eric Haas; Steven Jarrett; Daniel Leas; Animita Saha; Sharon Schiro; Bradley Watling Journal: J Addict Med Date: 2019 Sep/Oct Impact factor: 3.702
Authors: Patrick D Quinn; Kwan Hur; Zheng Chang; Eric L Scott; Erin E Krebs; Matthew J Bair; Martin E Rickert; Robert D Gibbons; Kurt Kroenke; Brian M D'Onofrio Journal: JAMA Pediatr Date: 2018-05-01 Impact factor: 16.193
Authors: Pooja A Lagisetty; Lewei A Lin; Dara Ganoczy; Rebecca L Haffajee; Theodore J Iwashyna; Amy S B Bohnert Journal: Med Care Date: 2019-10 Impact factor: 2.983
Authors: Kelsey C Priest; Travis I Lovejoy; Honora Englander; Sarah Shull; Dennis McCarty Journal: J Gen Intern Med Date: 2020-04-14 Impact factor: 5.128
Authors: Honora Englander; Konrad Dobbertin; Bonnie K Lind; Christina Nicolaidis; Peter Graven; Claire Dorfman; P Todd Korthuis Journal: J Gen Intern Med Date: 2019-12 Impact factor: 5.128
Authors: Patrick D Quinn; Kwan Hur; Zheng Chang; Erin E Krebs; Matthew J Bair; Eric L Scott; Martin E Rickert; Robert D Gibbons; Kurt Kroenke; Brian M D'Onofrio Journal: Pain Date: 2017-01 Impact factor: 7.926